Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational

Nadine S Jahchan1, Young-Hyun You, William J Muller

  • 1Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, USA.

Cancer Research
|May 13, 2010
PubMed

Insights

SnoN, a transforming growth factor-beta (TGF-beta) regulator, promotes mammary epithelial cell proliferation and accelerates involution. Elevated SnoN cooperates with oncogenes to drive aggressive mammary tumors and metastasis in mice.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Developmental Biology

Background:

  • SnoN is a key negative regulator of TGF-beta signaling.
  • Its role in normal mammalian epithelial cells, particularly in mammary development, remains undefined.
  • Previous studies reported both pro-oncogenic and anti-oncogenic activities of SnoN.

Purpose of the Study:

  • To investigate the function of SnoN in normal mouse mammary gland epithelial cells.
  • To determine the effects of elevated SnoN levels on mammary gland development and tumorigenesis.
  • To provide in vivo evidence for SnoN's role in mammalian cancer progression.

Main Methods:

  • Generated transgenic mice expressing a SnoN fragment under the MMTV promoter.
  • Analyzed mammary gland morphology, proliferation, and involution dynamics.
  • Assessed cooperation between elevated SnoN and polyoma middle T antigen in tumorigenesis.

Main Results:

  • SnoN elevation increased mammary side-branching and lobular-alveolar proliferation in virgin mice.
  • Elevated SnoN accelerated involution in postlactation mammary glands.
  • SnoN alone did not induce mammary tumors, but cooperated with polyoma middle T antigen to accelerate aggressive adenocarcinoma formation and pulmonary metastasis.

Conclusions:

  • SnoN plays critical roles in regulating mammary epithelial cell proliferation and gland involution.
  • This study provides the first in vivo evidence of a pro-oncogenic role for SnoN in mammalian mammary tumorigenesis.
  • SnoN acts as a cooperating oncogene in mammary cancer development and metastasis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...